StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)

Close on Nov 18, 2026Market cap $59.59MP/E –Yield –

Lensar total assets

Total assets on the balance sheet at the end of each period.

Lensar's total assets was $69.56M at Jun 30, 2026. For fiscal 2025 it was $71.43M, up 7.7% from the year before. The highest annual figure on record is $79.12M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$71.43M+7.7%
FY2024Dec 31, 2024$66.30M-4.7%
FY2023Dec 31, 2023$69.59M+24.6%
FY2022Dec 31, 2022$55.84M-16.0%
FY2021Dec 31, 2021$66.47M-16.0%
FY2020Dec 31, 2020$79.12M+129.1%
FY2019Dec 31, 2019$34.54M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$69.56M-1.2%
Q1 FY2026Mar 31, 2026$66.22M-9.2%
Q4 FY2025Dec 31, 2025$71.43M+7.7%
Q3 FY2025Sep 30, 2025$70.20M+13.2%
Q2 FY2025Jun 30, 2025$70.41M+14.7%
Q1 FY2025Mar 31, 2025$72.96M+10.3%
Q4 FY2024Dec 31, 2024$66.30M-4.7%
Q3 FY2024Sep 30, 2024$62.02M-12.5%
Q2 FY2024Jun 30, 2024$61.41M-13.8%
Q1 FY2024Mar 31, 2024$66.13M+27.3%
Q4 FY2023Dec 31, 2023$69.59M+24.6%
Q3 FY2023Sep 30, 2023$70.85M+29.3%
Q2 FY2023Jun 30, 2023$71.20M+21.3%
Q1 FY2023Mar 31, 2023$51.96M-13.8%
Q4 FY2022Dec 31, 2022$55.84M-16.0%
Q3 FY2022Sep 30, 2022$54.80M-19.5%
Q2 FY2022Jun 30, 2022$58.70M-19.0%
Q1 FY2022Mar 31, 2022$60.30M-18.0%
Q4 FY2021Dec 31, 2021$66.47M-16.0%
Q3 FY2021Sep 30, 2021$68.10M-15.6%
Q2 FY2021Jun 30, 2021$72.48M+109.9%
Q1 FY2021Mar 31, 2021$73.54M–
Q4 FY2020Dec 31, 2020$79.12M–
Q3 FY2020Sep 30, 2020$80.71M–
Q4 FY2019Dec 31, 2019$34.54M–

More Lensar figures

See a number that looks wrong?